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Abstract
Background: Three phenotypic identification systems (MicroScan, VITEK 2, and Crystal GP) were
evaluated for their accuracy to identify coagulase-negative staphylococci (CNS). A total of 120
clinical isolates confirmed to be CNS via 16S rRNA sequencing and analysis with the MicroSeq 500
v2.0 database were assessed.
Results: The MicroScan, VITEK 2, and Crystal GP systems correctly identified 82.5%, 87.5%, and
67.5% of the isolates, respectively. Misidentification was the main problem in MicroScan (10.8%)
and Crystal GP (23.3%) systems, whereas the main problem of VITEK 2 was low-level
discrimination (7.5%).
Conclusion: None of the 3 phenotypic systems tested could accurately and reliably identify CNS
at the species level. Further verifications such as biochemical testing or 16S rRNA sequencing
together with analysis using a comparable database might be helpful in this regard.
Background
Because of their ubiquity and low virulence, coagulase-
negative staphylococci (CNS) have generally been consid-
ered to be nonpathogens or simple contaminants.
Recently, their clinical significance is being increasingly
recognized with the elucidation of their pathogenicity.
CNS can form biofilms and have been demonstrated to
exhibit antibiotic resistance [1,2]. S. epidermidis, S. haemo-
lyticus, and S. lugdunensis, to a lesser extent, are well-
known etiological agents of implanted device-mediated
infections [2-5]. S. saprophyticus can cause community-
acquired infections of the uropoietic tract. Hence, species-
level identification of CNS is necessary for correct guid-
ance of clinicians in terms of appropriate treatment strat-
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egy, and a wide variety of identification methods have
been proposed.
Many automated phenotypic identification systems are
commercially available, including the MicroScan (Dade
Behring, West Sacramento, CA, USA), VITEK 2
(bioMérieux, Maray l'Etoile, France), and Crystal GP (Bec-
ton Dickinson, Sparks, MD, USA) systems. On the basis of
metabolic activities and/or morphological features, these
systems enable microbiologists to identify bacterial iso-
lates at the species level with greater ease, accuracy, and
rapidity than that previously achieved [6]. However, these
systems have several potential problems: (i) different
strains in one species may not exhibit a specific character-
istic, (ii) isolates from old cultures may not show the
expected biochemical patterns, (iii) isolates from a host
who has undergone long-term antimicrobial therapy may
alter their typical biochemical characteristics, (iv) the
same strain may not yield the same results in repeated
tests, (v) the databases have data on a limited number of
species, (vi) phenotypic variation may affect the accuracy
of species-level identification by automated phenotypic
systems, and (vii) phenotypic systems often suggest 2 or
more designations with comparable probability levels [6-
9].
Recently, genotypic methods are emerging as the new
standard for bacterial identification in automated labora-
tories [4,6,7,10-14]. 16S ribosomal RNA (rRNA)
sequences comprising both variable and conserved
regions allow for clear differentiation between organisms
not only at the species level but also at the subspecies level
[10]. These sequences permit better identification of rare
or phenotypically aberrant species as well as noncultura-
ble bacteria. The MicroSeq 500 system (Applied Biosys-
tems Inc. [ABI], Foster City, CA, USA) is a commercially
available software system for 16S rRNA analysis.
Despite the increasing clinical significance of CNS and the
growing use of automated phenotypic systems in clinical
laboratories, few studies have systematically evaluated the
accuracy of these systems [4,9,15]. In the present study,
the accuracy of 3 commercial phenotypic systems (Micro-
Scan, VITEK 2, and Crystal GP) for CNS identification was
compared. 16S rRNA sequencing and MicroSeq 500 anal-
ysis were used as references [10-12,16-19].
Results
Clinical isolates
By using in-house primers and the MicroSeq 500 v2.0
database, we successfully identified all the 120 clinical
isolates with more than 97% matches (data not shown).
The identified species were as follows: 16 S. capitis, 4 S.
caprae, 3 S. cohnii, 53 S. epidermidis, 4 S. haemolyticus, 25 S.
hominis, 6 S. lugdunensis, 1 S. saprophyticus, 2 S. simulans,
and 6 S. warneri. Blood culture specimens primarily con-
tained S. epidermidis, whereas a variety of uncommon CNS
were isolated from pitted keratolysis specimens. The result
reflected the typical distribution of staphylococcal species
detected routinely in microbiology laboratories.
Identification using MicroScan
The overall performances of 3 phenotypic systems are
summarized in Table 1 and the incorrect identification
results are listed in Table 2. Of 120 isolates, correct iden-
tification, low-level discrimination and misidentification
were 82.5% (99), 6.7% (8) and 10.8% (13), respectively.
Nonidentification was not observed. Three S. caprae iso-
lates were not correctly identified (isolate number: M211,
M215, and M225), because the species S. caprae is not
included in the MicroScan version 2.0 or 2.1 database.
One of the S. epidermidis isolates (M106) was misidenti-
fied as S. aureus.
Identification using VITEK 2
In the VITEK 2 analysis, correct identification, low-level
discrimination and misidentification were 87.5% (105),
7.5% (9) and 5.0% (6), respectively. Nonidentification
did not occur. Of note, the analysis of 6 S. epidermidis iso-
lates (6/53, 11.3%) resulted in low-level discriminations
– multiple identifications as S. hominis, S. epidermidis, or
Aerococcus viridans with low percent probabilities, suggest-
ing S. hominis with the highest percent probability fol-
lowed by S. epidermidis (M123, M124, M125, M126,
M127, M137).
Identification using Crystal GP
Crystal GP is not as fully automated as the other two, as
the reading of the biochemical reaction depends on man-
ual reading. In order to prevent the bias resulting from
manual reading, the biochemical reaction results were
read by two different technicians, followed by repeated
tests on wrongly identified isolates or those with multiple
identifications or nonidentifications. The identification
results of 81 isolates (67.5%) using the Crystal GP system
agreed with those of the MicroSeq 500 system with confi-
dence factors of more than 0.9 (correct identifications). In
total, 23.3% (28) were misidentified, and 9.2% (11)
could not be identified (nonidentification). Low-level dis-
crimination was not observed. Misidentifications at the
genus level occurred for 1 S. epidermidis and 1 S. hominis
isolate (M112, M216). The Crystal GP system correctly
identified all the isolates of S. cohnii, S. haemolyticus, S.
saprophyticus, S. simulans, and S. warneri.
Discussion
With the increased attention being given to the clinical
significance of CNS, clinical laboratories must correctly
identify CNS at the species level by using reliable and
reproducible methods. Because clinical microbiology lab-BMC Microbiology 2008, 8:233 http://www.biomedcentral.com/1471-2180/8/233
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oratories are increasingly becoming dependent on auto-
mated systems, the accuracy of these systems must be
investigated. In the present study, the accuracy of 3 phe-
notypic identification systems for CNS identification was
tested and compared with the sequencing of 16S rRNA.
MicroScan and VITEK 2 showed similar concordance rate
to MicroSeq 500. VITEK 2 showed a slightly higher "cor-
rect identification" rate (82.5% vs. 87.5%, respectively).
When the low-level discrimination results that included
the correct identification were considered together, the
concordance rates were 89.2% (107/120) for MicroScan
and 95.0% (114/120) for VITEK 2. Crystal GP had the
lowest correct identification rate (67.5%). All 3 systems
had misidentifications: single but incorrect identification
results with higher than acceptable probability of over
85%, which is consistent with the system manufacturer's
reported homology value without additional verification,
or with higher than a confidence factor of 0.9. This indi-
cates that CNS identifications made using these pheno-
Table 1: Clinical isolates and identification results from MicroScan, VITEK2, and Crystal GP
Clinical Isolates (using MicroSeq 500) No of isolates Correct Identificationa Low-level Discriminationb Misidentificationc Nonidentificationd
MicroScan
S. capitis 16 13 (81.3%) - 3 (18.8%) -
S. caprae 4- - 4  ( 1 0 0 . 0 % ) -
S. cohnii 3 1 (33.3%) 1 (33.3%) 1 (33.3%) -
S. epidermidis 53 51 (96.2%) - 2 (3.8%) -
S. haemolyticus 4 3 (75.0%) 1 (25.0%) - -
S. hominis 25 23 (92.0%) 2 (8.0%) - -
S. lugdunensis 6 2 (33.3%) 1 (16.7%) 3 (50.0%) -
S. saprophyticus 1 1 (100.0%) - - -
S. simulans 2 2 (100.0%) - - -
S. warneri 6 3 (50.0%) 3 (50.0%) - -
Subtotal 120 99 (82.5%) 8 (6.7%) 13 (10.8%) -
VITEK 2
S. capitis 16 16 (100.0%) - - -
S. caprae 4 3 (75.0%) - 1 (25.0%) -
S. cohnii 3 3 (100.0%) - - -
S. epidermidis 53 47 (88.7%) 6 (11.3%) - -
S. haemolyticus 4 4 (100.0%) - - -
S. hominis 25 22 (88.0%) 1 (4.0%) 2 (8.0%) -
S. lugdunensis 6 5 (83.3%) 1 (16.7%) - -
S. saprophyticus 1 1 (100.0%) - - -
S. simulans 2 1 (50.0%) 1 (50.0%) - -
S. warneri 6 3 (50.0%) - 3 (50.0%) -
Subtotal 120 105 (87.5%) 9 (7.5%) 6 (5.0%) -
Crystal GP
S. capitis 16 13 (81.3%) - 3 (18.8%) -
S. caprae 4- - 4  ( 1 0 0 . 0 % ) -
S. cohnii 3 3 (100.0%) - - -
S. epidermidis 53 49 (92.5%) - 3 (5.7%) 1 (1.9%)
S. haemolyticus 4 4 (100.0%) - - -
S. hominis 25 1 (4.0%) - 15 (60.0%) 9 (36.0%)
S. lugdunensis 6 2 (33.3%) - 3 (50.0%) 1 (16.7%)
S. saprophyticus 1 1 (100.0%) - - -
S. simulans 2 2 (100.0%) - - -
S. warneri 6 6 (100.0%) - - -
Subtotal 120 81 (67.5%) - 28 (23.3%) 11 (9.2%)
Correct identificationa: single, unambiguous, correct identification at the species level
Low-level discriminationb: two or more possible species level identification including the correct one
Misidentificationc: genus or species-level identification different from that obtained with the reference method
Nonidentificationd: no identification or unidentificationBMC Microbiology 2008, 8:233 http://www.biomedcentral.com/1471-2180/8/233
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Table 2: Identification results with percent probability or confidence factor of single wrong identification or multiple identifications in 
three phenotypic systems
MicroSeq 500 MicroScan VITEK2 Cystal GP
M102 S. epidermidis S. epidermidis 91.36% S. epidermidis 97.10% S. intermedius
M104 S. epidermidis S. xylosus 95.12% S. epidermidis 99.00% S. epidermidis
M106 S. epidermidis S. aureus 87.13% S. epidermidis 99.00% S. epidermidis
M107 S. capitis S. simulans 88.95% S. capitis 98.78% S. capitis
M112 S. epidermidis S. epidermidis 99.99% S. epidermidis 99.00% K. sedentarius
M117 S. lugdunensis S. haemolyticus 90.39% S. lugdunensis 99.00% Nonidentification
M118 S. lugdunensis S. haemolyticus 96.86% S. lugdunensis 90.37% S. haemolyticus
M120 S. hominis S. hominis 94.57% S. hominis 95.00% Nonidentification
M123 S. epidermidis S. epidermidis 98.20% S. hominis, S. epidermidis, A. viridans 
33.82%, 33.09%, 33.09%
S. epidermidis
M124 S. epidermidis S. epidermidis 99.25% S. hominis, S. epidermidis 50.27%, 49.73% Nonidentification
M125 S. epidermidis S. epidermidis 98.20% S. hominis, S. epidermidis 50.27%, 49.73% S. epidermidis
M126 S. epidermidis S. epidermidis 99.99% S. hominis, S. epidermidis, A. viridans 
33.71%, 33.33%, 32.96%
S. epidermidis
M127 S. epidermidis S. epidermidis 99.99% S. hominis, S. epidermidis 50.28%, 47.92% S. epidermidis
M128 S. hominis S. hominis 94.58% S. hominis 94.86% S. saprophyticus
M130 S. capitis S. epidermidis 90.20% S. capitis 92.00% S. capitis
M137 S. epidermidis S. epidermidis 95.28% S. hominis, S. epidermidis 50.56%, 49.44% S. epidermidis
M138 S. capitis S. capitis 95.28% S. capitis 98.86% S. auricularis
M139 S. capitis S. capitis 99.60% S. capitis 98.86% S. hominis
M141 S. epidermidis S. epidermidis 99.99% S. epidermidis 98.16% S. hominis
M149 S. capitis S. epidermidis 90.20% S. capitis 92.00% S. capitis
M153 S. hominis S. hominis 97.44% S. hominis 99.00% Nonidentification
M154 S. hominis S. hominis 94.62% S. hominis 98.35% Nonidentification
M155 S. hominis S. hominis 97.44% S. hominis 97.21% S. warneri, S. saprophyticus 0.5574, 
0.4415
M156 S. hominis S. hominis 95.00% S. hominis 97.00% S. saprophyticus
M157 S. warneri S. warneri, S. cohnii, S. capitis, etc. 60.92%, 
15.78%, 12.67%.
S. cohnii, S. vitulinus 50.54%, 49.46% S. warneri
M158 S. warneri S. warneri 90.92% S. cohnii 90.54% S. warneri
M160 S. hominis S. hominis, S. capitis, S. warneri, etc. 37.58%, 
24.33%, 20.21%.
S. hominis 93.79% Nonidentification
M161 S. hominis S. hominis 94.57% S. hominis 96.98% S. saprophyticus
M162 S. caprae S. hominis 92.35% S. auricularis 90.40% S. saprophyticus
M163 S. hominis S. hominis 98.82% S. hominis 98.50% Nonidentification
M166 S. hominis S. hominis 85.00% S. hominis 98.82% Nonidentification
M167 S. hominis S. hominis 93.05% S. caprae 96.97% S. caprae
M176 S. simulans S. simulans 96.77% S. simulans, S. warneri 50.28%, 49.72% S. simulans
M17 S. hominis S. simulans 99.09% S. haemolyticus 96.74% S. haemolyticus
M179 S. hominis S. epidermidis, S. hominis 68.34%, 31.66% S. hominis 94.88% Nonidentification
M180 S. hominis S. hominis 92.77% S. hominis 93.56% S. warneri
M181 S. hominis S. hominis 92.77% S. hominis, S. warneri 50.27%, 49.73% S. warneri
M182 S. hominis S. hominis 94.57% S. hominis 95.00% Nonidentification
M183 S. hominis S. hominis 88.68% S. hominis 91.00% S. saprophyticus
M184 S. hominis S. hominis 92.13% S. hominis 99.00% S. intermedius
M185 S. hominis S. hominis 96.01% S. hominis 96.81% S. capitis
M186 S. hominis S. hominis 98.50% S. hominis 95.00% S. aureus, S. intermedius
M187 S. hominis S. hominis 98.50% S. hominis 99.00% Nonidentification
M203 S. hominis S. hominis 97.44% S. hominis 97.27% S. cohnii
M205 S. warneri S. warneri, S. capitis, S. hominis 86.37%, 
7.96%, 5.67%
S. saphrophyticus 98.03% S. warneri
M207 S. lugdunensis S. haemolyticus 98.08% S. lugdunensis 99.00% S. lugdunensis
M208 S. haemolyticus S. haemolyticus, S. simulans, S. warneri 
54.38%, 41.97%, 3.66%
S. haemolyticus 94.74% S. haemolyticus
M209 S. hominis S. hominis 97.44% S. hominis 97.76% S. cohnii
M210 S. cohnii S. cohnii, S. xylosus 67.28%, 29.12% S. cohnii 99.00% S. cohnii
M211 S. caprae S. aureus, S. capitis 69.87%, 29.25% S. caprae 98.60% S. intermidius
M212 S. capitis S. capitis 99.11% S. capitis 98.56% S. vitulus
M213 S. warneri S. auricularis, S. hominis, S. warneri 45.13%, 
27.55%, 24.55%
S. warneri 95.00% S. warneriBMC Microbiology 2008, 8:233 http://www.biomedcentral.com/1471-2180/8/233
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typic systems cannot always be considered accurate,
regardless of the reported probability.
In MicroScan analysis, none of the S. caprae identifica-
tions were correct (3 low-level identifications and 1 misi-
dentification). This is because the species S. caprae is not
included in the MicroScan database, which illustrates the
inappropriateness of this database. Ambiguous identifica-
tions, including low-level discriminations and misidenti-
fications, were observed for 8 out of 10 species (with the
exception of S. saprophyticus and  S. warneri) with the
MicroScan system, compared with 6 ambiguous identifi-
cations with the VITEK2 system and 5 with the Crystal GP
system. This finding was consistent with results reported
by other researchers who found that the MicroScan system
has greater accuracy in the identification of S. epidermidis
and S. saprophyticus than for identification of other species
[20-22]. The other notable finding of the present study is
that 1 S. epidermidis isolate from blood culture was misi-
dentified as S. aureus with 87.5% probability, which could
have delayed appropriate treatment for the patient.
In VITEK 2 analysis, low-level discriminations of 6 S. epi-
dermidis  isolates (11.3% of S. epidermidis isolates)
occurred, compared to higher correct identification rates
with the MicroScan and Crystal GP systems (96.2% and
92.5%, respectively). Some researchers reported different
sort of difficulties in identifying S. epidermidis with VITEK
2 [9,23,24]. However, others reported high accuracy of
VITEK 2 for the identification of staphylocccal species
[25,26]. The performance of VITEK 2 in the identification
of CNS including S. epidermidis seems not to be deter-
mined yet, and the additional testing such as manual bio-
chemical testing or sequencing is required for the accurate
diagnosis.
The Crystal GP system provides no guidelines for the
interpretation of the confidence factor, therefore, all iso-
lates with confidence factors lower than 0.9 were retested.
In spite of repeated testing, this system had the lowest cor-
rect identification rate and the highest rate of nonidentifi-
cation.
One limitation of this study is that additional biochemi-
cal testing was not preformed. 16S rRNA sequencing
might not be a perfect method for interspecies discrimina-
tion. However, not all the suggested biochemical tests are
available in many automated laboratories or based on our
experience, manual testing could not resolve the ambigu-
ity of CNS identification in many cases. To improve relia-
bility in this study, all isolates with discrepancies or
uncertain results were retested using isolates preserved in
skim milk at -70°C.
Conclusion
None of the tested systems (MicroScan, VITEK 2, Crystal
GP) are able to accurately identify all of the staphylococ-
cal species evaluated in this study. Additional verification
via molecular testing or suggested biochemical tests may
prove helpful for correct CNS identification.
Methods
Clinical isolates
A total of 120 clinical isolates (95 blood culture isolates,
25 skin isolates from pitted keratolysis patients) were used
in this study [27]. To exclude simple contaminants, only
isolates of blood cultures that grew in more than 2 of 3
blood cultures were included. The pitted keratolysis spec-
imen was obtained after repeated washing of the lesion
with normal saline by scratching the lesion with a sterile
blade into a sterile conical tube. The isolates were tested
within 24 hours. For additional tests or repeated tests, the
isolates were suspended in skim milk, stored at -70°C and
retested. All of the isolates were confirmed to be CNS by
use of 16S rRNA sequencing with MicroSeq 500 software
(version 2.0) with over 97% matches.
Phenotypic identification of CNS
Three phenotypic systems were evaluated: MicroScan Pos
Combo panel type 1A (Dade Behring, West Sacramento,
CA, USA), VITEK 2 GP-ID cards (bioMérieux, Marcy
l'Etoile, France), and Crystal Gram Positive ID systems
(Becton Dickinson, Sparks, MD, USA). Bacterial suspen-
sions were prepared from well-isolated colonies. The col-
onies were suspended in the broth provided by each
company, and the turbidity was adjusted to 0.5 McFar-
land. MicroScan Pos Combo panel type 1A was inocu-
M214 S. lugdunensis S. lugdunensis 98.81% S. lugdunensis 95.00% S. simulans
M215 S. caprae S. capitis, S. aureus 62.82%, 35.76% S. caprae 99.00% S. cohnii
M216 S. hominis S. hominis 97.44% S. hominis 97.76% M. kristinae
M221 S. lugdunensis S. lugdunensis, S. haemoiyticus, S. hominis 
62.62%, 28.34%, 9.04%
S. lugdunensis, S. warneri 50.00%, 50.00% S. lugdunensis
M222 S. lugdunensis S. lugdunensis 96.30% S. lugdunensis 91.26% S. simulans
M224 S. cohnii S. xylosus 91.70% S. cohnii 99.00% S. cohnii
M225 S. caprae S. warneri, S. simulans, S. epidermidis 70.19%, 
13.84%, 12.32%
S. caprae 99.00% S. capitis
Table 2: Identification results with percent probability or confidence factor of single wrong identification or multiple identifications in 
three phenotypic systems (Continued)BMC Microbiology 2008, 8:233 http://www.biomedcentral.com/1471-2180/8/233
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lated according to the manufacturer's recommendations
and processed with a MicroScan Walkaway 96 apparatus.
The blood culture isolates were analyzed using a MicroS-
can LabPro system (version 2.0) and the skin isolates were
analyzed with version 2.01. VITEK 2 GP-ID cards were
used in combination with a VITEK 2 system (version 4.02)
for all isolates. The Crystal GP results were read manually
by 2 different technicians using the Crystal GP Identifica-
tion Color Chart.
The MicroScan system classifies identification results into
4 categories by percent probability: species identified with
high probability (> 85%), species identified with low
probability (< 85%), very rare biotype, and group ID (>
85% but genus or group identified only). The VITEK 2 sys-
tem categorizes the identification results by probability:
excellent (96%–99%), very good (93%–95%), good
(89%–92%), acceptable (85%–88%), low discrimination
(2–3 identifications with 100% probability in total), and
nonidentification. The Crystal GP system gives confidence
factors instead of probability; however, there are no such
criteria in terms of the confidence factor. When the confi-
dence factor is low, Crystal GP reports non-identification,
which necessitates additional manual testing.
The results of incorrect identifications (not concordant to
that of MicroSeq 500) regardless of probability, identifica-
tion with unacceptable probability (lower than 85% for
MicroScan and VITEK 2) or low confidence factor (lower
than 0.9 for Crystal GP), or nonidentification were
retested with colonies that were stored in skim milk at -
70°C. Those with incorrect, or consistently unacceptable
or nonidentifiable results are listed in Table 2. The confi-
dence factor of the Crystal GP system is not included, as
there are no guidelines for these interpretations.
16S rRNA sequencing
To extract bacterial DNA, InstaGene Matrix (Bio-Rad Lab-
oratories, Hercules, CA, USA) was used. Two or 3 colonies
of each isolate were suspended in 100 μl sterile distilled
water and centrifuged for 5 min at 15,000 rpm. A 200 μl
aliquot of InstaGene Matrix (Bio-Rad Laboratories, Her-
cules, CA, USA) was added to the sediment. The mixture
was heat-lysed for 5 min at 100°C, cooled at room tem-
perature, and centrifuged for 3 min at 15,000 rpm. The
supernatant (2.5 μl) of each bacterial extract was used for
successive amplification procedures. Polymerase chain
reaction (PCR) was conducted in a total volume of 25 μl
containing 2.5 mM dNTP, 10 pmol of each PCR primer,
0.6 units Taq polymerase, 2.5 μl 10 × PCR buffer with 15
mM MgCl2 (Takara Bio, Inc., Shiga, Japan), and 2.5 μl
template. In-house primers were designed using the Light-
Cycler Probe Design software (version 2.0) (Roche, Penz-
berg, Germany), using published studies as a reference
[8,9]. The primers used for amplification were MSQ-F (5'-
TGA AGA GTT TGA TCA TGG CTC AG-3') and MSQ-R (5'-
ACC GCG GCT GCT GGC AC-3'). The PCR conditions
were as follows: 10 min of initial denaturation at 95°C,
followed by 35 cycles of annealing of 30s at 95°C, 30s at
60°C, 45s at 72°C, and a final 10-minute extension at
72°C. Gel electrophoresis was used to detect positive PCR
signals and to confirm the length of the amplicon. Prior to
sequencing, the PCR products were purified using
ExoSAP-IT reagent (USB Corporation, Cleveland, Ohio,
USA) according to the manufacturer's instructions. For-
ward and reverse sequencing reactions were conducted for
each of the amplified products. The sequencing reaction
consisted of 10 μl MicroSeq 500 sequencing mix (contain-
ing 1.6 pmol of MSQ-F and MSQ-R primers), 2.9 μl sterile
distilled water, and 1 μl purified PCR product. Sequencing
reactions were performed using Big Dye terminator rea-
gents on an ABI Prism 3130xl Genetic Analyzer (Applied
Biosystems Inc., Foster City, CA, USA) according to stand-
ard automated sequencer protocols.
Sequence analysis
MicroSeq 500 version 2.0 software was used for sequence
analysis. The analysis steps were as follows: (i) the forward
and reverse sequences were assembled into one consensus
sequence, (ii) the consensus sequence was edited to
resolve discrepancies between the 2 strands by evaluating
the electropherograms, and (iii) the consensus sequence
was compared with sequences in the MicroSeq 500 data-
base. The comparison, using the full alignment tool of the
MicroSeq 500 software, generated a list of the closest
matches with a distance score, which indicates the per-
centage difference between the unknown sequence and
the database sequence. Only when the consensus
sequence had more than a 97% match with that of the
MicroSeq 500 results, the identification results were con-
sidered to be acceptable [7,10].
Analysis of the results
The results of 16S rRNA sequencing and MicroSeq 500
analysis were regarded as the definitive identification [10-
12,16-19]. The species-level identification and percent
probability from phenotypic systems were all taken into
consideration. The concordance of the results of the phe-
notypic systems with those of MicroSeq 500 were classi-
fied into 4 categories according to the following
definitions: (i) correct identification (unambiguous, sin-
gle identification identical to that of MicroSeq 500 at the
species level, with > 85% probability in MicroScan and
VITEK 2 or 0.9 confidence factor); (ii) low-level discrimi-
nation (2 or more possible species-level identifications,
including the correct one, with probability < 85% in
MicroScan and VITEK 2 or the low confidence factor
under 0.9 in Crystal GP); (iii) misidentification (genus-
level or species-level identification different from that
obtained with the reference method) and (iv) nonidenti-Publish with BioMed Central    and   every 
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fication (isolates that were unable to be identified at the
species level in spite of the repeated testing).
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